{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:26:03Z","timestamp":1761017163827},"reference-count":22,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1507\/endocrj.ej16-0289","type":"journal-article","created":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T18:10:19Z","timestamp":1474999819000},"page":"75-81","source":"Crossref","is-referenced-by-count":4,"title":["Usefulness of urinary glucose excretion after oral glucose tolerance testing to detect insulin secretion failure before the onset of diabetes mellitus"],"prefix":"10.1507","volume":"64","author":[{"given":"Yosuke","family":"Ono","sequence":"first","affiliation":[{"name":"Department of General Medicine, National Defense Medical College, Tokorozawa, Japan"},{"name":"Department of Internal Medicine, Japan Self Defense Forces Central Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hinata","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Japan Self Defense Forces Central Hospital, Tokyo, Japan"},{"name":"Hinata Clinic, Sayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimitsu","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Japan Self Defense Forces Central Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Japan Self Defense Forces Central Hospital, Tokyo, Japan"},{"name":"Wakagi Clinic, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of General Medicine, National Defense Medical College, Tokorozawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Takahara M, Shiraiwa T, Matsuoka T, Katakami N, Shimomura I (2015) Ameliorated pancreatic β cell dysfunction in type 2 diabetic patients treated with a sodium-glucose cotransporter 2 inhibitor ipragliflozin. Endocr J<\/i> 62: 77-86.","DOI":"10.1507\/endocrj.EJ14-0335"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Fujishima M, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, et al<\/i>. (1996) Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes<\/i> 45: S14-S16.","DOI":"10.2337\/diab.45.3.S14"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, et al<\/i>. (1999) Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care<\/i> 22: 920-924.","DOI":"10.2337\/diacare.22.6.920"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus, Seino Y, Nanjo K, Tajima N, Kadowaki T, et al<\/i>. (2010) Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. J Diabetes Investig<\/i> 1: 212-228.","DOI":"10.1111\/j.2040-1124.2010.00074.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Takahara M, Katakami N, Matsuoka T, Noguchi M, Shimomura I (2015) An inverse U-shaped association of late and peak insulin levels during an oral glucose load with glucose intolerance in a Japanese population: a cross-sectional study. Endocr J<\/i> 62: 217-226.","DOI":"10.1507\/endocrj.EJ14-0240"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Islam SK, Seo M, Lee YS, Moon SS (2015) Association of periodontitis with insulin resistance, β-cell function, and impaired fasting glucose before onset of diabetes. Endocr J<\/i> 62: 981-989.","DOI":"10.1507\/endocrj.EJ15-0350"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Okita K, Iwahashi H, Kozawa J, Okauchi Y, Funahashi T, et al<\/i>. (2013) Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy. Endocr J<\/i> 60: 283-290.","DOI":"10.1507\/endocrj.EJ12-0320"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Clar C, Gill JA, Court R, Waugh N (2012) Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes. BMJ Open<\/i> 2: e001007.","DOI":"10.1136\/bmjopen-2012-001007"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Iozzo P, Beck-Nielsen H, Laakso M, Smith U, Yki-Jarvinen H, et al<\/i>. (1999) Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab<\/i> 84: 863-868.","DOI":"10.1210\/jcem.84.3.5542"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Basu R, Breda E, Oberg AL, Powell CC, Dalla Man C, et al<\/i>. (2003) Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alternations in insulin secretion, action, and clearance. Diabetes<\/i> 52: 1738-1748.","DOI":"10.2337\/diabetes.52.7.1738"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chang AM, Halter JB (2003) Aging and insulin secretion. Am J Physiol Endocrinol Metab<\/i> 284: E7-E12.","DOI":"10.1152\/ajpendo.00366.2002"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lawrence RD (1940) Renal threshold for glucose: normal and in diabetics. Br Med J<\/i> 1: 766-768.","DOI":"10.1136\/bmj.1.4140.766"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kilpatrick ES, Keevilt BG, Richmond KL, Newland P, Addison GM (1999) Plasma 1,5-anhydroglucitol concentrations are influenced by variations in the renal threshold for glucose. Diabet Med<\/i> 16: 496-499.","DOI":"10.1046\/j.1464-5491.1999.00093.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Butterfield WJ, Keen H, Whichelow MJ (1967) Renal glucose threshold variations with age. Br Med J<\/i> 4: 505-507.","DOI":"10.1136\/bmj.4.5578.505"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Feingold KR (1980) The danger of a changing renal threshold for glucose. Diabetes Care<\/i> 3: 570-571.","DOI":"10.2337\/diacare.3.4.570"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Walford S, Page MM, Allison SP (1980) The influence of renal threshold on the interpretation of urine tests for glucose in diabetic patients. Diabetes Care<\/i> 3: 672-674.","DOI":"10.2337\/diacare.3.6.672"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, et al<\/i>. (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care<\/i> 20: 537-544.","DOI":"10.2337\/diacare.20.4.537"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, et al<\/i>. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med<\/i> 344: 1343-1350.","DOI":"10.1056\/NEJM200105033441801"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al<\/i>. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med<\/i> 346: 393-403.","DOI":"10.1056\/NEJMoa012512"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kosaka K, Noda M, Kuzuya T (2005) Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract<\/i> 67: 152-162.","DOI":"10.1016\/j.diabres.2004.06.010"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, et al<\/i>. (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification andmetformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDDP-1). Diabetologia<\/i> 49: 289-297.","DOI":"10.1007\/s00125-005-0097-z"},{"key":"22","unstructured":"22. Centers for Disease Control and Prevention (CDC) (2013) Awareness of prediabetes—United State, 2005-2010. MMWR Morb Mortal Wkly Rep<\/i> 62: 209-212."}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/1\/64_EJ16-0289\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T22:09:03Z","timestamp":1568412543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/64\/1\/64_EJ16-0289\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej16-0289","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}